Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results-Reference-Cited by-同舟云学术

Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results

Published:2007-03 Issue:4 Volume:67 Page:1099-1105
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Madsen Berit L.,Hsi R. Alex,Pham Huong T.,Fowler Jack F.,Esagui Laura,Corman John

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference16 articles.

1. Is α/β for prostate tumors really low?;Fowler;Int J Radiat Oncol Biol Phys,2001

2. Fractionation and protraction for radiotherapy of prostate carcinoma;Brenner;Int J Radiat Oncol Biol Phys,1999

3. What is the α/β ratio for prostate cancer? Rationale for hypofractionated high-dose rate brachytherapy;Duchesne;Int J Radiat Oncol Biol Phys,1999

4. Comparison of rectal dose volume histograms for definitive prostate radiotherapy among stereotactic radiotherapy, IMRT, and 3D-CRT techniques;Madsen;Int J Radiat Oncol Biol Phys,2004

5. Intrafractional stability of the prostate using a stereotactic radiotherapy technique;Madsen;Int J Radiat Oncol Biol Phys,2003

Cited by 342 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer;Clinical and Translational Radiation Oncology;2024-01

2. The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer—Quo Vadimus?;World Journal of Urology;2023-11-03

3. Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 Trial;International Journal of Radiation Oncology*Biology*Physics;2023-11

4. Disease control outcomes of stereotactic body radiation therapy or moderate hypo‐fractionation for prostate cancer: Real‐world experience at two Canadian centers;The Prostate;2023-10-25

5. Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: 5-Year Toxicity and Biochemical Recurrence Results From a Prospective Trial;Practical Radiation Oncology;2023-09